DE69614681D1 - Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten - Google Patents

Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Info

Publication number
DE69614681D1
DE69614681D1 DE69614681T DE69614681T DE69614681D1 DE 69614681 D1 DE69614681 D1 DE 69614681D1 DE 69614681 T DE69614681 T DE 69614681T DE 69614681 T DE69614681 T DE 69614681T DE 69614681 D1 DE69614681 D1 DE 69614681D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
antioxyding
dietic
compositions
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69614681T
Other languages
English (en)
Other versions
DE69614681T2 (de
Inventor
Roberto Bianchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
FARMILA FARMA MILANO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMILA FARMA MILANO filed Critical FARMILA FARMA MILANO
Publication of DE69614681D1 publication Critical patent/DE69614681D1/de
Application granted granted Critical
Publication of DE69614681T2 publication Critical patent/DE69614681T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DE69614681T 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten Expired - Lifetime DE69614681T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Publications (2)

Publication Number Publication Date
DE69614681D1 true DE69614681D1 (de) 2001-09-27
DE69614681T2 DE69614681T2 (de) 2002-07-04

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614681T Expired - Lifetime DE69614681T2 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Country Status (11)

Country Link
US (1) US5866537A (de)
EP (1) EP0825871B1 (de)
JP (1) JP4850986B2 (de)
AT (1) ATE204479T1 (de)
AU (1) AU697990B2 (de)
CA (1) CA2221455C (de)
DE (1) DE69614681T2 (de)
ES (1) ES2159737T3 (de)
IT (1) IT1275434B (de)
PT (1) PT825871E (de)
WO (1) WO1996036348A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014063A1 (en) * 1994-11-08 1996-05-17 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
CA2327095A1 (en) * 1998-04-02 1999-10-14 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
PT1100589E (pt) 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
CA2339473A1 (en) * 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
MXPA03002068A (es) * 2000-09-14 2004-09-10 Univ Nebraska Compuestos y formulaciones pro-nutrientes de ester de creatina.
PT1285654E (pt) * 2001-03-16 2006-08-31 Cerebos Pacific Ltd Agentes de controlo do sistema autonomo e alimentos e bebidas para a saude.
JP2005528424A (ja) * 2002-06-04 2005-09-22 アビセナ グループ インコーポレイティッド 脳内エネルギー代謝を調節することによって認知機能障害を治療する方法
TR200301291A2 (tr) * 2002-08-20 2004-02-23 Dart Industries Inc. Şekil verilmiş gıda maddelerinin oluşturulması için ayarlanabilir kalıp
JP2006504701A (ja) * 2002-09-30 2006-02-09 マーク・エー・バビザイェフ 眼疾患の局所的治療方法、並びに、その治療用組成物及び治療用手段
JPWO2004064866A1 (ja) * 2003-01-20 2006-05-18 イノヴェイティブ ヴィジョン プロダクツ インコーポレーテッド カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
PL2233127T3 (pl) 2004-03-17 2020-11-16 Stada Arzneimittel Ag Zastosowanie przeciwutleniaczy do wytwarzania kompozycji farmaceutycznej lub kosmetycznej do ochrony skóry przed uszkodzeniem wywołanym przez promieniowanie podczerwone
WO2005120543A1 (en) 2004-06-08 2005-12-22 Flamma, S.P.A. Compositions containing d-carnosine
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
KR101275660B1 (ko) 2005-05-23 2013-06-17 내츄럴 얼터너티브즈 인터내셔날, 인크. 베타-알라닌의 지속적 방출을 위한 조성물 및 방법
WO2007133673A2 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
JPWO2011078204A1 (ja) * 2009-12-24 2013-05-09 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
RU2013133994A (ru) * 2010-12-21 2015-01-27 Нестек С.А. Способы и композиции, применимые для контроля глюкозы в крови животных
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
TWI775921B (zh) 2017-08-14 2022-09-01 美商胺細拉健康公司 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US20220218640A1 (en) * 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP2023156812A (ja) * 2022-04-13 2023-10-25 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
AU697990B2 (en) 1998-10-22
ES2159737T3 (es) 2001-10-16
US5866537A (en) 1999-02-02
ITMI951021A1 (it) 1996-11-19
IT1275434B (it) 1997-08-07
AU5897496A (en) 1996-11-29
JP4850986B2 (ja) 2012-01-11
ATE204479T1 (de) 2001-09-15
WO1996036348A1 (en) 1996-11-21
EP0825871A1 (de) 1998-03-04
PT825871E (pt) 2001-12-28
JPH11505540A (ja) 1999-05-21
DE69614681T2 (de) 2002-07-04
ITMI951021A0 (it) 1995-05-19
CA2221455C (en) 2008-07-08
EP0825871B1 (de) 2001-08-22
CA2221455A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
DE69614681D1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
AU4114296A (en) Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
ATE335462T1 (de) Pharmazeutische und/oder kosmetische zusammensetzungen enthaltend meerwasser
EP1166767A3 (de) Hautpflegemittel enthaltend Hydroxyprolin oder N-Acetylhydroxyprolinderivate
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
ES2092266T3 (es) Composiciones para la nutricion ingeribles oralmente, que tienen apetibilidad mejorada.
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
AU7575394A (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
PL320560A1 (en) Pharmaceutic composition
CA2212904A1 (en) The activity-inhibitor and activity-potentiator for glutamic acid in the brain
ATE151636T1 (de) Diphosphonsäuren und deren salze enthaltende arzneimittel
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
MX9300558A (es) Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene.
KR950010884A (ko) 사람 및 동물에서 염증성 반응을 일으키는 공격 또는 패혈증 치료용의 아미노산계 조성물
ATE383332T1 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
DK0707853T3 (da) Muselrelakserende farmaceutiske præparater
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
BR0111579A (pt) Sais duplos de ácido fumárico com uma carnitina e um aminoácido e suplementos alimentares, suplementos diéteticos e drogas contendo os mesmos
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
GB9505082D0 (en) Medicament
ES2168508T3 (es) Empleo de treonina para el tratamiento de fenil-cetonuria.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIGMA-TAU HEALTHSCIENCE S.P.A., POMEZIA, IT

8327 Change in the person/name/address of the patent owner

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P, IT